Oncology How can an engineering background change the approach to dev... Sometimes all it takes to make a breakthrough in research, in any field, is to look at the problem differently than anybody has before.
Events Partner Content Drug Delivery Devices Symposium This one-of-a-kind event brings together global leaders
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.